Clinical Trial Update: Anti Xa Levels Under Two Different Regimens of Enoxaparin VTE Prophylaxis After Sleeve Gastrectomy for Morbid Obesity [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update examines anti-Xa levels under two regimens of enoxaparin for VTE prophylaxis after sleeve gastrectomy in morbid obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morbid Obesity
• Obesity

Drugs mentioned

• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Obesity | Phase 4 | Status: UNKNOWN